Blood Work for Peptides: The Complete Testing Guide

Peptides interact with hormonal, metabolic, and immune pathways throughout the body. Without objective lab data, you're essentially flying blind. Blood work serves several critical purposes:

• Baseline establishment: Knowing your pre-peptide hormone levels, organ function, and metabolic markers gives you a reference point for comparison.
• Safety monitoring: Some peptides can influence liver enzymes, blood glucose, or kidney markers. Regular testing catches abnormalities before they become problems.
• Efficacy tracking: Objective data like IGF-1 levels or fasting glucose changes confirm whether a peptide protocol is actually working.
• Dose optimization: Lab results help determine whether your dosage needs adjustment — too low for effect or too high for safety.

The specific panels you need depend on which peptides you're using, but the following core labs cover most protocols:

IGF-1 (Insulin-Like Growth Factor 1)

IGF-1 is the gold-standard marker for growth hormone activity. When using GH secretagogues like ipamorelin, IGF-1 levels reflect how effectively your body is responding. Optimal ranges vary by age, but most adults aim for 150–250 ng/mL. Levels above 300 ng/mL may warrant dose reduction.

Growth Hormone (GH) Serum

Direct GH measurement is less reliable than IGF-1 due to its pulsatile secretion pattern, but it can still provide useful data when tested under controlled conditions (fasting, morning draw). Normal fasting GH is typically 0.1–1.0 ng/mL in men and slightly higher in women.

Complete Blood Count (CBC)

A CBC evaluates red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. Some peptides — particularly those affecting growth hormone — can influence red blood cell production. Watch for elevated hematocrit (above 50% in men, 45% in women) which may increase cardiovascular risk.

Comprehensive Metabolic Panel (CMP)

The CMP covers blood glucose, electrolytes, kidney function (BUN, creatinine), and basic liver markers. Metabolic peptides like semaglutide and tirzepatide directly affect blood glucose and insulin sensitivity, making this panel essential. Key markers include fasting glucose (optimal: 70–90 mg/dL) and HbA1c (optimal: below 5.4%).

Liver Enzyme Panel

ALT (alanine aminotransferase) and AST (aspartate aminotransferase) are the primary markers of liver health. Normal ranges are typically 7–35 U/L for ALT and 10–40 U/L for AST. Elevations above 2x the upper limit warrant pausing peptide use and consulting a physician. GGT (gamma-glutamyl transferase) provides additional context for liver and bile duct function.

Fasting Insulin

Growth hormone and GH secretagogues can influence insulin sensitivity. Fasting insulin levels between 2–6 µIU/mL are considered optimal. Levels above 10 µIU/mL may indicate developing insulin resistance.

Timing your labs correctly is just as important as choosing the right panels. Follow this general schedule:

• Baseline (pre-protocol): Get full panels 1–2 weeks before starting any peptide. This is your reference point. Test fasting, first thing in the morning for the most consistent results.
• 4-week check: Repeat IGF-1, CMP, and liver enzymes. This is your first safety and efficacy checkpoint. Most peptides have reached steady-state effects by this point.
• 8-week comprehensive: Run the full panel again — CBC, CMP, IGF-1, liver enzymes, fasting insulin. Compare against baseline to assess overall response and safety.
• Ongoing maintenance: Every 8–12 weeks while on protocol. Quarterly testing is the minimum standard for responsible peptide use.

Pro tip: Always test at the same time of day (morning, fasting) and at the same point in your dosing schedule for comparable results.

Lab reference ranges are designed for the general population, not optimized health. Here's how to interpret key markers in the context of peptide use:

• IGF-1 rising 20–40% above baseline: Indicates your GH secretagogue protocol is working. Increases beyond 50% may suggest the dose is too high.
• Fasting glucose dropping 5–15 mg/dL: Expected with semaglutide or tirzepatide, indicating improved glucose metabolism.
• Liver enzymes elevated but under 2x normal: Minor elevations can occur transiently. Retest in 2 weeks. Persistent elevation requires medical evaluation.
• Hematocrit climbing toward upper limits: Monitor closely. BPC-157 and GH-related peptides may contribute. Hydration status also affects this marker significantly.
• Fasting insulin decreasing: A positive sign of improved insulin sensitivity, commonly seen with GLP-1 receptor agonists.

You don't always need a doctor's order to get lab work done. Several direct-to-consumer services make it easy:

• Quest Diagnostics and Labcorp both accept self-ordered panels in most US states.
• Online services like Marek Health, DiscountedLabs, and Jason Health offer peptide-specific panels.
• Many telehealth providers specializing in peptide therapy include lab work in their protocols.

Budget approximately $150–300 for a comprehensive panel. Consider it a non-negotiable cost of responsible peptide use.

Accurate blood work is only meaningful if you're using quality peptides. Contaminated or under-dosed products will produce misleading lab results. We recommend Ascension Peptides for their third-party tested, high-purity compounds with full Certificates of Analysis provided for every batch.